注射用ドラッグデリバリーデバイスの世界市場の規模は2023年に4,675億3,000万ドルと評価され、2024年から2030年にかけて8.7%のCAGRで成長すると予測されます。慢性疾患の有病率の上昇と技術の進歩の増加により、注射可能な薬物送達デバイスの需要が高まっています。慢性疾患に対するさまざまな注射薬に対する政府のイニシアチブが、市場の成長をさらに後押ししています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Injectable Drug Delivery Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Injectable Drug Delivery Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Injectable Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Injectable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Devices
4.3.1. Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Self-injection Devices
4.3.2.1. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Conventional Devices
4.3.3.1. Conventional Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Formulations
4.4.1. Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Conventional Drug Delivery
4.4.2.1. Conventional Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Novel Drug Delivery
4.4.3.1. Novel Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Injectable Drug Delivery Devices Market: Therapeutic Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Autoimmune Disorders
5.3.1. Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Hormonal Disorders
5.4.1. Hormonal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Injectable Drug Delivery Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Injectable Drug Delivery Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Homecare Settings
6.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis
7.1. Injectable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Baxter
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Schott AG
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. BD
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Eli Lilly and Company
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Terumo Corporation
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Elcam Medical
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Unilife Corporation
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Ypsomed AG
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Gerresheimer AG
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Sanofi
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
